Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| DOV PHARMACEUTICAL INC | 3,228,500 | reported | 16 May 2008 | tx 15+13,013,209−5,830,709 |
| Adaptimmune Therapeutics PLC | 500,000 | reported | 01 Jul 2022 | tx 6+1,534,786 |
| Ovid Therapeutics Inc. | 65,000 | reported | 26 Feb 2026 | tx 15+347,850 |
| Atea Pharmaceuticals, Inc. | 62,750 | reported | 20 Jun 2025 | tx 13+459,539−62,750 |
| Innoviva, Inc. | 52,318 | reported | 20 Apr 2017 | tx 2+52,318 |
| INTERCEPT PHARMACEUTICALS INC | 30,661 | reported | 03 Oct 2016 | tx 112+240,602−267,195 |
| HALOZYME THERAPEUTICS, INC. | 6,040 | reported | 05 May 2026 | tx 9+55,680 |
| MEDGENICS, INC. | 0 | reported | 03 Feb 2020 | tx 14+270,115−200,115 |
| Fusion Pharmaceuticals Inc. | 0 | reported | 04 Jun 2024 | tx 8+81,000−81,000 |
| IMMUNOMEDICS INC | 0 | reported | 23 Oct 2020 | tx 14+99,079−99,079 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 May 2026 | GRANT_AWARD | HALOZYME THERAPEUTICS, INC. | 3,796 | 0.00 USD | |
| 05 May 2026 | GRANT_AWARD | HALOZYME THERAPEUTICS, INC. | 6,040 | 0.00 USD | deriv |
| 26 Feb 2026 | GRANT_AWARD | Ovid Therapeutics Inc. | 65,000 | 0.00 USD | deriv |
| 20 Jun 2025 | EXERCISE | Atea Pharmaceuticals, Inc. | 29,600 | 0.00 USD | |
| 20 Jun 2025 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 41,200 | 0.00 USD | deriv |
| 20 Jun 2025 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 29,600 | 0.00 USD | deriv |
| 20 Jun 2025 | EXERCISE | Atea Pharmaceuticals, Inc. | 29,600 | 0.00 USD | deriv |
| 20 Feb 2025 | GRANT_AWARD | Ovid Therapeutics Inc. | 45,000 | 0.00 USD | deriv |
| 01 May 2025 | GRANT_AWARD | HALOZYME THERAPEUTICS, INC. | 4,165 | 0.00 USD | |
| 01 May 2025 | GRANT_AWARD | HALOZYME THERAPEUTICS, INC. | 5,750 | 0.00 USD | deriv |
| 12 Dec 2024 | GRANT_AWARD | Ovid Therapeutics Inc. | 90,000 | 0.00 USD | deriv |
| 21 Jun 2024 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 29,600 | 0.00 USD | deriv |
| 21 Jun 2024 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 41,200 | 0.00 USD | deriv |
| 16 Jun 2024 | EXERCISE | Atea Pharmaceuticals, Inc. | 33,150 | 0.00 USD | |
| 16 Jun 2024 | EXERCISE | Atea Pharmaceuticals, Inc. | 33,150 | 0.00 USD | deriv |
| 04 Jun 2024 | OTHER | Fusion Pharmaceuticals Inc. | 30,000 | — | deriv |
| 04 Jun 2024 | OTHER | Fusion Pharmaceuticals Inc. | 17,000 | — | deriv |
| 04 Jun 2024 | OTHER | Fusion Pharmaceuticals Inc. | 17,000 | — | deriv |
| 04 Jun 2024 | OTHER | Fusion Pharmaceuticals Inc. | 17,000 | — | deriv |
| 25 Apr 2024 | GRANT_AWARD | HALOZYME THERAPEUTICS, INC. | 6,501 | 0.00 USD | |
| 25 Apr 2024 | GRANT_AWARD | HALOZYME THERAPEUTICS, INC. | 8,804 | 0.00 USD | deriv |
| 22 Feb 2024 | GRANT_AWARD | Ovid Therapeutics Inc. | 30,000 | 0.00 USD | deriv |
| 16 Jun 2023 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 33,150 | 0.00 USD | deriv |
| 16 Jun 2023 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 46,750 | 0.00 USD | deriv |
| 14 Jun 2023 | GRANT_AWARD | Fusion Pharmaceuticals Inc. | 17,000 | 0.00 USD | deriv |